Testing effectiveness (Phase 2)Study completedNCT00100633
What this trial is testing
Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People
Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 30